iBio (AMEX:IBIO) reported its Q3 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
iBio missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05.
Revenue was up $1.18 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 2.66% drop in the share price the next day.
Here's a look at iBio's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | |||
| EPS Actual | -0.05 | -0.04 | -0.05 | -0.04 |
| Revenue Estimate | 250.00K | 491.00K | 1.00M | 800.00K |
| Revenue Actual | 168.00K | 211.00K | 491.00K | 765.00K |
To track all earnings releases for iBio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
